Complications of transcatheter closure of atrial septal defects.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 1769242)

Published in Heart on August 23, 2005

Authors

M S Spence, S A Qureshi

Articles cited by this

Comparison between transcatheter and surgical closure of secundum atrial septal defect in children and adults: results of a multicenter nonrandomized trial. J Am Coll Cardiol (2002) 6.01

Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients. J Am Coll Cardiol (2004) 5.44

Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol (2002) 5.41

A comparison of surgical and medical therapy for atrial septal defect in adults. N Engl J Med (1995) 4.99

Long-term outcome after surgical repair of isolated atrial septal defect. Follow-up at 27 to 32 years. N Engl J Med (1990) 4.70

Secundum atrial septal defect. Nonoperative closure during cardiac catheterization. JAMA (1976) 3.82

Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv (2004) 3.08

Congenital heart disease among 160 480 liveborn children in Liverpool 1960 to 1969. Implications for surgical treatment. Br Heart J (1981) 2.80

Excellent survival and low incidence of arrhythmias, stroke and heart failure long-term after surgical ASD closure at young age. A prospective follow-up study of 21-33 years. Eur Heart J (2003) 2.49

Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience. Heart (1999) 1.88

Experience with transcatheter closure of secundum atrial septal defects using the Amplatzer septal occluder: a single centre study in 236 consecutive patients. Heart (2003) 1.86

Surgical patch closure of atrial septal defects. Ann Thorac Surg (2004) 1.17

The gold standard for atrial septal defect closure: current surgical results, with an emphasis on morbidity. Pediatr Cardiol (2003) 1.06

Use of suture-mediated vascular closure devices for the management of femoral vein access after transcatheter procedures. Catheter Cardiovasc Interv (2004) 0.96

Articles by these authors

(truncated to the top 100)

Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell (1994) 5.79

Role of STAT2 in the alpha interferon signaling pathway. Mol Cell Biol (1995) 2.34

Transcatheter embolization in the treatment of coronary artery fistulas. J Am Coll Cardiol (1991) 2.17

Transcatheter coil occlusion of the arterial duct; results of the European Registry. Eur Heart J (2001) 1.99

Middle aortic syndrome treated by stent implantation. Heart (1999) 1.75

Transcatheter closure of patent arterial ducts using controlled-release coils. Eur Heart J (1997) 1.69

Influence of anatomic correction for transposition of the great arteries on myocardial perfusion: radionuclide imaging with technetium-99m 2-methoxy isobutyl isonitrile. J Am Coll Cardiol (1994) 1.68

Determinants of hemodynamic results of balloon dilation of aortic recoarctation. Am J Cardiol (1992) 1.53

Managed Care Network for the assessment of cardiac problems in children in a district general hospital: a working model. Arch Dis Child (2006) 1.40

Stent implantation for aortic coarctation and recoarctation. Heart (1999) 1.36

Reactive oxygen intermediates target CC(A/T)6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc Natl Acad Sci U S A (1993) 1.32

Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation: incidence and contributing factors (the UK CoreValve Collaborative). Circulation (2011) 1.30

Transcription: new insights from studies on Archaea. Trends Genet (1995) 1.29

Suspected angina pectoris: a rapid-access chest pain clinic. QJM (2001) 1.28

Evaluation of selected hypolipidemic agents for the induction of peroxisomal enzymes and peroxisome proliferation in the rat liver. Hum Toxicol (1983) 1.20

Cardiovascular collapse after verapamil in supraventricular tachycardia. Arch Dis Child (1987) 1.20

Excessive accumulation of autofluorescent lipofuscin in the liver during hepatocarcinogenesis by methyl clofenapate and other hypolipidemic peroxisome proliferators. Cancer Res (1982) 1.16

Induction of hepatic peroxisome proliferation in nonrodent species, including primates. Am J Pathol (1984) 1.14

Protein-losing enteropathy caused by baffle obstruction after Mustard's operation. Br Heart J (1988) 1.12

Successful occlusion of a coronary arteriovenous fistula using an Amplatzer duct occluder. Cardiol Young (2001) 1.11

Radiofrequency-assisted balloon dilatation in patients with pulmonary valve atresia and an intact ventricular septum. Br Heart J (1993) 1.11

Induction and origin of hepatocytes in rat pancreas. J Cell Biol (1984) 1.10

Evidence that v-src and v-fps gene products use a protein kinase C-mediated pathway to induce expression of a transformation-related gene. Proc Natl Acad Sci U S A (1989) 1.10

Technique of percutaneous laser-assisted valve dilatation for valvar atresia in congenital heart disease. Br Heart J (1993) 1.09

Chronic treatment with a glucagon receptor antagonist lowers glucose and moderately raises circulating glucagon and glucagon-like peptide 1 without severe alpha cell hypertrophy in diet-induced obese mice. Diabetologia (2011) 1.08

Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells. Oncogene (1992) 1.07

Balloon dilatation of critical stenosis of the pulmonary valve in neonates. Br Heart J (1990) 1.07

Spontaneous pneumonediastinum associated with pulmonary cavitation. Postgrad Med J (1980) 1.06

Endarterectomy of the left coronary system. Analysis of a 10 year experience. J Thorac Cardiovasc Surg (1985) 1.06

Closure of aortopulmonary window with amplatzer duct occluder device. Pediatr Cardiol (2003) 1.05

The efficacy and safety of stent redilatation in congenital heart disease. Heart (2003) 1.05

Stent implantation for aortic recoarctation. Am Heart J (1995) 1.02

Prenatal detection and progression of right coronary artery to right ventricle fistula. Heart (1996) 1.01

Interlocking detachable platinum coils, a controlled embolization device: early clinical experience. Cardiovasc Intervent Radiol (1996) 1.01

Tumorigenicity of the hypolipidaemic peroxisome proliferator ethyl-alpha-p-chlorophenoxyisobutyrate (clofibrate) in rats. Br J Cancer (1979) 1.00

Use of the Amplatzer muscular ventricular septal defect occluder for closure of perimembranous ventricular septal defects. Heart (2006) 1.00

Evolving use of embolisation coils for occlusion of the arterial duct. Heart (1996) 0.99

Interventions complementing surgery as part of multistage treatment for hypoplastic left heart syndrome: one center's experience. Pediatr Cardiol (2008) 0.99

Effects of modified and classic Blalock-Taussig shunts on the pulmonary arterial tree. Ann Thorac Surg (1998) 0.99

Diagnosis of Alagille syndrome-25 years of experience at King's College Hospital. J Pediatr Gastroenterol Nutr (2011) 0.99

Development of hepatocellular carcinomas and increased peroxisomal fatty acid beta-oxidation in rats fed [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (Wy-14,643) in the semipurified diet. Carcinogenesis (1981) 0.98

Successful long-term ventricular pacing via the coronary sinus after the Fontan operation. Pacing Clin Electrophysiol (1995) 0.98

Development of dopaminergic neurons in the human substantia nigra. Exp Neurol (1991) 0.96

Immunochemical identity of peroxisomal enoyl-CoA hydratase with the peroxisome-proliferation-associated 80,000 mol wt polypeptide in rat liver. J Cell Biol (1981) 0.96

Streptokinase for aortic thrombosis. Arch Dis Child (1988) 0.96

RNAi-mediated germline knockdown of FABP4 increases body weight but does not improve the deranged nutrient metabolism of diet-induced obese mice. Int J Obes (Lond) (2010) 0.95

Growth of the right ventricle after successful transcatheter pulmonary valvotomy in neonates and infants with pulmonary atresia and intact ventricular septum. J Thorac Cardiovasc Surg (1998) 0.95

Differentiation and DNA synthesis in pancreatic acinar carcinoma of rat. Cancer Res (1980) 0.94

Extended-spectrum beta-lactamase in Salmonella spp. J Hosp Infect (1995) 0.93

The intercellular adhesion molecule-1 (ICAM-1) gene K469E polymorphism is not associated with ischaemic heart disease: an investigation using family-based tests of association. Eur J Immunogenet (2004) 0.92

Induction of hamster hepatic peroxisomal beta-oxidation and peroxisome proliferation-associated 80000 mol. wt. polypeptide by hypolipidemic drugs. Hum Toxicol (1982) 0.91

MARCKS protein is transcriptionally down-regulated in v-Src-transformed BALB/c 3T3 cells. J Biol Chem (1992) 0.91

Stent implantation in congenital heart disease. Br Heart J (1992) 0.91

Response of hepatocytes transplanted into syngeneic hosts and heterotransplanted into athymic nude mice to peroxisome proliferators. Cancer Res (1984) 0.90

v-Fps-responsiveness in the Egr-1 promoter is mediated by serum response elements. Nucleic Acids Res (1992) 0.89

In vivo mitochondrial DNA-protein interactions in sea urchin eggs and embryos. Curr Genet (1999) 0.89

Total anomalous pulmonary venous drainage. Seventeen-year surgical experience. J Thorac Cardiovasc Surg (1988) 0.89

Evidence that activation of the Egr-1 promoter by v-Raf involves serum response elements. Oncogene (1992) 0.88

Anomalous origin of the left coronary artery from the pulmonary trunk. Anatomic findings in relation to pathophysiology and surgical repair. J Thorac Cardiovasc Surg (1989) 0.88

Three- and four-dimensional reconstruction of intra-cardiac anatomy from two-dimensional magnetic resonance images. Int J Cardiovasc Imaging (2003) 0.88

Growth of the pulmonary artery after neonatal balloon dilatation of the right ventricular outflow tract in an infant with the tetralogy of Fallot and atrioventricular septal defect. Br Heart J (1989) 0.88

Closed atrial septectomy with Brock punch aided by operative transesophageal echocardiography. Ann Thorac Surg (1995) 0.88

Medium-term results of experimental stent implantation into the ductus arteriosus. Am Heart J (1996) 0.88

Pulmonary artery tear following balloon valvoplasty in Fallot's tetralogy. Int J Cardiol (1987) 0.86

An evaluation of right and left ventricular function after anatomical correction and intra-atrial repair operations for complete transposition of the great arteries. Circulation (1990) 0.85

Is the prevention of infective endarteritis a valid reason for closure of the patent arterial duct? Eur Heart J (1997) 0.85

Morphological evaluation of atrioventricular septal defects by magnetic resonance imaging. Br Heart J (1990) 0.85

Secretion granules of transplantable pancreatic acinar carcinoma of rat. Biochem J (1980) 0.84

Percutaneous pulmonary valvotomy and arterial duct stenting in neonates with right ventricular hypoplasia. Am J Cardiol (1994) 0.84

Percutaneous transcatheter retrieval of misplaced therapeutic embolisation devices. Br Heart J (1994) 0.83

Noninhibitory effect of antioxidants ethoxyquin, 2(3)-tert-butyl-4-hydroxyanisole and 3,5-di-tert-butyl-4-hydroxytoluene on hepatic peroxisome proliferation and peroxisomal fatty acid beta-oxidation induced by a hypolipidemic agent in rats. Cancer Res (1983) 0.83

Jugular venous aneurysm in children. Br J Radiol (1988) 0.83

The induction of Egr-1 expression by v-Fps is via a protein kinase C-independent intracellular signal that is sequentially dependent upon HaRas and Raf-1. Cell Growth Differ (1992) 0.82

Doppler echocardiographic comparison of haemodynamic results of one- and two-stage anatomic correction of complete transposition. Int J Cardiol (1988) 0.82

Ha-Ras functions downstream from protein kinase C in v-Fps-induced gene expression mediated by TPA response elements. Oncogene (1993) 0.82

Magnetic resonance imaging of the great arteries in infants. Int J Cardiol (1990) 0.82

Doppler echocardiography after anatomical correction of transposition of the great arteries. Br Heart J (1986) 0.82

Acquired supravalvar membranous stenosis of the left atrioventricular valve. Br Heart J (1987) 0.81

Aortic coarctation and recoarctation: to stent or not to stent? J Interv Cardiol (2001) 0.81

Interventional and surgical management of aortic stenosis and coarctation. Ann Thorac Surg (2001) 0.81

Selection of patients with secundum atrial septal defects for transcatheter device closure. Eur Heart J (2000) 0.81

Pulmonary regurgitation in transposition of the great arteries. Br Heart J (1987) 0.80

Percutaneous pacemaker lead extraction and stent implantation for superior vena cava occlusion due to pacemaker leads. Am J Cardiol (1996) 0.80

Diaphoretic therapy in regular dialysis patients. Scott Med J (1982) 0.80

Transcatheter embolization of coronary artery fistula with controlled release coils. J Paediatr Child Health (1996) 0.80

Use of a second transcatheter Rashkind arterial duct occluder for persistent flow after implantation of the first device: indications and results. Br Heart J (1993) 0.80

Double-outlet right ventricle: morphologic demonstration using nuclear magnetic resonance imaging. J Am Coll Cardiol (1991) 0.79

Stenting of systemic venous pathways after atrial repair for complete transposition. Heart (1998) 0.79

Closure of atrial septal defects by transcatheter devices. Pediatr Cardiol (1997) 0.79

Should balloon angioplasty be used instead of surgery for native aortic coarctation? Heart (1997) 0.79

Peroxisome development in the regenerating pars recta (P3 segment) of proximal tubules of the rat kidney. J Histochem Cytochem (1976) 0.78

Effect of introducing balloon dilation of native aortic coarctation on overall outcome in infants and children. Am J Cardiol (1994) 0.78

The connexin 37 gene polymorphism and coronary artery disease in Ireland. Heart (2006) 0.78

Mitral valve disease in Marfan's syndrome. Arch Dis Child (1987) 0.78

Comparison of balloon dilation and stent implantation to maintain patency of the neonatal arterial duct in lambs. Am J Cardiol (1993) 0.78

Xenografting of fetal pig ventral mesencephalon corrects motor asymmetry in the rat model of Parkinson's disease. Exp Brain Res (1989) 0.78

Evaluation of pulmonary artery anatomy using magnetic resonance: the importance of multiplanar and oblique imaging. Pediatr Cardiol (1994) 0.77

Hemodynamic response to continuous infusion of dobutamine in Alagille's syndrome. Transplantation (2001) 0.77

Assessment of in vitro percutaneous absorption of glycolic acid through human skin sections using a flow-through diffusion cell system. J Dermatol Sci (1998) 0.77

Single pass VDD pacing in children and adolescents. Pacing Clin Electrophysiol (1997) 0.77